For More Information
Interested in learning about how Linical Americas can impact your next study?Learn More
Join Our investigator Network
Interested in becoming part of the Linical Americas Investigator network?Learn More
STUART, FL. April 29, 2021 -
Did you know walking is associated with lower mortality and better longevity, mental health, and cognitive functioning, as well as lower risk of some types of cancer?
This year Linical Americas and more than 50 of its employees nationwide will help lead the fight against cancer by participating in the American Cancer Society CEOs Against Cancer® Fit2BeCancerFree CEOs Challenge.
Staying fit can help reduce your cancer risk. To help you stay healthy, the Society is hosting a national step tracking challenge. CEOs and executives around the country will step up at work, inspiring thousands of colleagues to get active in the fight against cancer.
There will be a CEO Challenge and Three Week Employee Challenge. Both challenges begin April 29. Recognition will be shared via ACS’ CEO Twitter and LinkedIn page as well as the Top 3 CEO winners will have the opportunity for a personal virtual chat with the Society’s new CEO.
There are more than 500 members of the American Cancer Society CEOs Against Cancer program who represent a powerful network that includes the most prominent names in business today. Members bring the passion, expertise and resources needed to prevent, treat, and cure this disease, which costs U.S. employers $225.8 billion each year.
About the American Cancer Society:
The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, to free lodging near treatment, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is attacking cancer from every angle. For more information go to www.cancer.org
Linical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, infectious disease, and CNS. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.